Page last updated: 2024-11-03
propofol and Bannayan-Riley-Ruvalcaba Syndrome
propofol has been researched along with Bannayan-Riley-Ruvalcaba Syndrome in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Pancaro, C | 1 |
Miller, T | 1 |
Dingeman, RS | 1 |
Other Studies
1 other study available for propofol and Bannayan-Riley-Ruvalcaba Syndrome
Article | Year |
---|---|
Anesthetic management of a child with Bannayan-Riley-Ruvalcaba syndrome.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Child; Female; Hamartoma Syndrome, Multiple; Hema | 2008 |